Stuart Colligon, Chairman

Stuart has worked in senior positions in the health sector since 1998. He has been in the international pharmaceutical industry for 18 years, during which time he founded and established Panacea in 2008. His experience in the pharma industry has been built in the development and supply chain phases, and his entire career has been immersed in service provision. Stuart is committed to establishing excellent, honest and mutually rewarding partnerships within Panacea and with Panacea’s clients, and his service sector background ensures that this is a natural element of Panacea’s culture. Having set up and run several successful businesses, he gives Panacea the grounding to grow confidently to ensure that it will be a long-term, sustainable partner of choice for the best companies in the industry.

stewart_mbl

Stuart Colligon, Chairman

Stuart has worked in senior positions in the health sector since 1998. He has been in the international pharmaceutical industry for 18 years, during which time he founded and established Panacea in 2008. His experience in the pharma industry has been built in the development and supply chain phases, and his entire career has been immersed in service provision. Stuart is committed to establishing excellent, honest and mutually rewarding partnerships within Panacea and with Panacea’s clients, and his service sector background ensures that this is a natural element of Panacea’s culture. Having set up and run several successful businesses, he gives Panacea the grounding to grow confidently to ensure that it will be a long-term, sustainable partner of choice for the best companies in the industry.

Anne Dougherty, Operations Director

Anne has worked in the pharmaceutical industry for over 20 years in both pharmacovigilance and regulatory affairs. She graduated with a BSc(Hons) in Biochemistry and went on to gain the Postgraduate Diploma in Pharmacovigilance whilst working at Pharmacia and Upjohn in 1999. Her experience in Pharmacovigilance is from both clinical trial and post marketing adverse event reporting including provision of medical information and assistance in product launches. She has been involved in inspections from both the MHRA and FDA and has successfully lead clients through the process of audit and inspection. Anne’s role as Head of Pharmacovigilance at Panacea is intended to ensure that the procedures in place are adhered to and that Panacea provides a quality of service to its clients acceptable to any inspecting authority.

anned_mbl

Anne Dougherty, Operations Director

Anne has worked in the pharmaceutical industry for over 20 years in both pharmacovigilance and regulatory affairs. She graduated with a BSc(Hons) in Biochemistry and went on to gain the Postgraduate Diploma in Pharmacovigilance whilst working at Pharmacia and Upjohn in 1999. Her experience in Pharmacovigilance is from both clinical trial and post marketing adverse event reporting including provision of medical information and assistance in product launches. She has been involved in inspections from both the MHRA and FDA and has successfully lead clients through the process of audit and inspection. Anne’s role as Head of Pharmacovigilance at Panacea is intended to ensure that the procedures in place are adhered to and that Panacea provides a quality of service to its clients acceptable to any inspecting authority.

Sally Francis, Director of QPPV Services

Sally joined Panacea in August 2011 as QPPV.  Sally is a qualified midwife and moved into the area of Pharmacovigilance over 16 years ago. Her experience  comes from working in two large global innovator pharmaceutical companies and one small UK generic company and includes post-marketing, clinical trials and devices. Sally was a member of the PIPA Signal Detection Working Party, which has now evolved into the new Benefit-Risk Management Working Party. She has been on both sides of the auditing table having successfully led clients through MHRA inspections and carrying out audits of prospective clients on behalf of Panacea.

sally_mbl

Sally Francis, Director of QPPV Services

Sally joined Panacea in August 2011 as QPPV.  Sally is a qualified midwife and moved into the area of Pharmacovigilance over 16 years ago. Her experience  comes from working in two large global innovator pharmaceutical companies and one small UK generic company and includes post-marketing, clinical trials and devices. Sally was a member of the PIPA Signal Detection Working Party, which has now evolved into the new Benefit-Risk Management Working Party. She has been on both sides of the auditing table having successfully led clients through MHRA inspections and carrying out audits of prospective clients on behalf of Panacea.

Helen Lowe, Head of Quality

Helen joined Panacea in February 2015.  She has worked in the pharmaceutical industry for 14 years in pharmacovigilance, quality and auditing roles.  As an auditor she has been involved with clinical trial site audits, pharmacovigilance audits and inspection preparation.  Within her latest roles she has been involved in the planning, implementing and preparation for audits and planning and preparation for inspections for numerous regulatory authorities including the MHRA and FDA.

helen_mbl

Helen Lowe, Head of Quality

Helen joined Panacea in February 2015.  She has worked in the pharmaceutical industry for 14 years in pharmacovigilance, quality and auditing roles.  As an auditor she has been involved with clinical trial site audits, pharmacovigilance audits and inspection preparation.  Within her latest roles she has been involved in the planning, implementing and preparation for audits and planning and preparation for inspections for numerous regulatory authorities including the MHRA and FDA.

Dr Liezl Schonken, Safety Physician

Liezl is responsible for the medical review of our clients’ pharmacovigilance documents and processes. Liezl’s commitment to consistently provide sound medical opinions and reviews allows the pharmacovigilance team and most importantly, our clients to feel secure and confident that every aspect has been covered. Through Panacea’s variety of clients, Liezl is involved in the medical review of many therapeutic areas, giving our clients a breadth of experience to call upon. Liezl is a GMC registered physician.

lizel_mbl

Dr Liezl Schonken, Safety Physician

Liezl is responsible for the medical review of our clients’ pharmacovigilance documents and processes. Liezl’s commitment to consistently provide sound medical opinions and reviews allows the pharmacovigilance team and most importantly, our clients to feel secure and confident that every aspect has been covered. Through Panacea’s variety of clients, Liezl is involved in the medical review of many therapeutic areas, giving our clients a breadth of experience to call upon. Liezl is a GMC registered physician.